Skip to main content
TECH logo

TECH

Bio-Techne Corporation

$72.48

0.11%

Trade Ideas Performance

Latest Closed Trade Idea

$72.48

0.11%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

7

Social

47

About

Events of Bio-Techne Corporation (TECH)

In Q3 Fiscal 2026, Bio-Techne reported a slight miss on both EPS and revenue, yet the stock rose by 7.38% due to investor optimism, despite a 2% organic revenue decline. Merck KGaA announced a definitive agreement to acquire Bio-Techne for $73 per share, leading to a 19.32% increase in Bio-Techne's stock price. Activist investor Ananym Capital Management built a stake and pressed for a strategic review, including a potential sale. Q4 Fiscal 2026 earnings reported adjusted EPS matching consensus and revenue surpassing estimates, with organic revenue increasing by 3%. Bio-Techne shareholders approved the acquisition by Merck KGaA in September 2026. In October 2026, Bio-Techne expanded its global GMP manufacturing network with a new facility in Bristol, UK, to advance scalable cell therapy development.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)